Core Laboratories NV (CLB) — Strategic Asset Allocation Index
Core Laboratories NV (CLB) has a Strategic Asset Allocation Index of 56.6% as of December 2025. Strategic assets (PP&E of $153.79 Million plus long-term investments of $4.43 Million) total $158.22 Million, measured against net assets of $279.76 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Core Laboratories NV liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Core Laboratories NV Strategic Asset Allocation Index (2000–2025)
This chart shows how Core Laboratories NV's Strategic Asset Allocation Index has evolved across 25 annual periods from 2000 to 2025. As of December 2025, the index stands at 56.6%, representing strategic assets of $158.22 Million against net assets of $279.76 Million USD. See Core Laboratories NV free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Core Laboratories NV (2000–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Core Laboratories NV from 2000 to 2025, covering 25 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see CLB company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 56.6% | $158.22 Million | $153.79 Million | $4.43 Million | $279.76 Million | ▼ -5.0 pp |
| 2024 | 61.5% | $158.63 Million | $153.55 Million | $5.08 Million | $257.74 Million | ▼ -7.3 pp |
| 2023 | 68.9% | $158.31 Million | $153.47 Million | $4.84 Million | $229.81 Million | ▼ -16.8 pp |
| 2022 | 85.7% | $161.86 Million | $157.41 Million | $4.45 Million | $188.95 Million | ▼ -24.0 pp |
| 2021 | 109.6% | $176.50 Million | $172.34 Million | $4.16 Million | $161.00 Million | ▼ -48.4 pp |
| 2020 | 158.0% | $119.39 Million | $115.29 Million | $4.09 Million | $75.57 Million | ▲ +88.0 pp |
| 2019 | 70.0% | $127.47 Million | $123.51 Million | $3.97 Million | $182.14 Million | ▼ -8.7 pp |
| 2018 | 78.7% | $126.68 Million | $122.92 Million | $3.76 Million | $160.90 Million | ▼ -6.4 pp |
| 2017 | 85.2% | $126.66 Million | $123.10 Million | $3.56 Million | $148.73 Million | ▼ -0.6 pp |
| 2016 | 85.7% | $133.11 Million | $129.88 Million | $3.22 Million | $155.30 Million | ▼ -75.3 pp |
| 2014 | 161.0% | $151.35 Million | $149.01 Million | $2.34 Million | $93.99 Million | ▲ +79.1 pp |
| 2013 | 82.0% | $138.82 Million | $138.82 Million | $- | $169.39 Million | ▲ +15.2 pp |
| 2012 | 66.7% | $125.42 Million | $125.42 Million | $- | $187.91 Million | ▲ +3.3 pp |
| 2011 | 63.5% | $115.30 Million | $115.30 Million | $- | $181.66 Million | ▲ +27.8 pp |
| 2010 | 35.7% | $104.22 Million | $104.22 Million | $- | $292.34 Million | ▲ +0.6 pp |
| 2009 | 35.1% | $98.78 Million | $98.78 Million | $- | $281.76 Million | ▼ -29.5 pp |
| 2008 | 64.5% | $103.46 Million | $103.46 Million | $- | $160.31 Million | ▼ -81.7 pp |
| 2007 | 146.2% | $93.04 Million | $93.04 Million | $- | $63.63 Million | ▲ +26.5 pp |
| 2006 | 119.7% | $87.73 Million | $87.73 Million | $- | $73.28 Million | ▲ +81.9 pp |
| 2005 | 37.8% | $81.34 Million | $81.34 Million | $- | $215.32 Million | ▼ -3.8 pp |
| 2004 | 41.6% | $79.62 Million | $79.62 Million | $- | $191.37 Million | ▼ -1.2 pp |
| 2003 | 42.8% | $94.81 Million | $94.81 Million | $- | $221.48 Million | ▲ +5.9 pp |
| 2002 | 36.9% | $95.45 Million | $95.45 Million | $- | $258.49 Million | ▲ +1.6 pp |
| 2001 | 35.3% | $97.61 Million | $97.61 Million | $- | $276.42 Million | ▲ +2.5 pp |
| 2000 | 32.8% | $83.34 Million | $83.34 Million | $- | $253.75 Million | — |